Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gallbladder Neoplasms × avelumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 13 Urinary Bladder Neoplasms 12 Neoplasms 10 Carcinoma, Renal Cell 9 Ovarian Neoplasms 7 Carcinoma, Transitional Cell 7 Neoplasm Metastasis 6 Pancreatic Neoplasms 5 Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Carcinoma, Merkel Cell 4 Triple Negative Breast Neoplasms 3 Recurrence 3 Lymphoma 3 Lung Neoplasms 3 Fallopian Tube Neoplasms 3 Colorectal Neoplasms 3 Stomach Neoplasms 2 Prostatic Neoplasms 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Kidney Neoplasms 2 Kidney Diseases 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Hepatocellular 2 Urothelial Cancer 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Turcot syndrome 1

Interventions

Gemcitabine 18 Cisplatin 10 Capecitabine 9 Oxaliplatin 6 pembrolizumab 4 Fluorouracil 4 Sorafenib 3 Magnetic Resonance Spectroscopy 3 Leucovorin 3 Erlotinib Hydrochloride 3 trifluridine tipiracil drug combination 2 regorafenib 2 cobimetinib 2 atezolizumab 2 Trastuzumab 2 Taxes 2 Specimen Handling 2 Platinum 2 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2 Lapatinib 2 Biopsy 2 Bevacizumab 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2 zanidatamab 1 varlilumab 1 vandetanib 1 tucatinib 1 trametinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡